Drug delivery play Crossject planning French IPO

Crossject S.A. (Chenove, France) said it plans to sell 1.5 million shares at EUR 7.21-EUR 8.38 in an IPO on Euronext Paris and a private placement to institutional investors outside the U.S. At the EUR 7.80 midpoint, the company would raise EUR 12 million ($16.2 million) and be valued at EUR 51.1 million ($69 million). CM-CIC Securities is bookrunner and listing sponsor. Crossject is slated to start trading on Euronext on Feb. 20. ...